Cysts Clinical Trial
— DETECTIONOfficial title:
How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
Verified date | April 2023 |
Source | Maastricht University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Multicenter trial about anterior mediastinal cysts
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 1, 2024 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: cysts in the anterior mediastinum - Thymic cysts - Bronchogenic cysts - Pericardial cysts - Cystic thymoma - Cystic teratoma Exclusion Criteria: - Patients <18 years old - Patients without radiological imaging - Patients without approval for follow-up |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht UMC | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center | Erasmus Medical Center, The Netherlands Cancer Institute |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage correctly diagnosed cystic laesions | 2000-2022 | ||
Secondary | Patient characteristics, complications, comborbidities | 2000-2022 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00280514 -
Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration
|
Phase 4 | |
Completed |
NCT01087060 -
Detection of Renal Malignancy of Complicated Renal Cysts
|
N/A | |
Completed |
NCT00001912 -
Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
|
N/A |